What Happened?
, -based Fresenius Kabi Appointed Andreas Duenkel as Chief Financial Officer
Date of management change: June 23, 2022
, -based Fresenius Kabi Appointed Andreas Duenkel as Chief Financial Officer
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and medical technologies for infusion, transfusion and clinical nutrition. Our expansive portfolio of products and global network of science and manufacturing centers provide essential support for the care of critical and chronically ill patients. We are part of Fresenius SE, a health care group with more than 100 years of experience in pharmaceuticals, medical devices and life sciences. Our employees – more than 35,000 worldwide – develop and deliver injectable pharmaceuticals and infusion systems; blood collection, transfusion and cell technologies; and essential nutrients for parenteral nutrition. We have special expertise in medicines for oncology, infection, anesthesia, analgesia and critical care. Our products are used in all sites of care – from hospitals and clinics to blood and plasma centers, and increasingly in patients’ homes. In biosimilars, we are developing products with a focus on oncology and autoimmune diseases.
Andreas Duenkel is Chief Financial Officer at Fresenius Kabi. Previously, Andreas held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Militello Joseph, Jordan David, Balius Suzanne, Balusu Anj, Gibbs Steven, Brenneman Chad, seach daniel, Potts Ashley, Darby Lauren, Matushak Jay, Kraft Warren
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.